India reports marginal increase in new coronavirus cases in 24 hours

India reported 1,938 fresh Covid cases, marginally higher than the previous day's count of 1,778, in a span of 24 hours.

coronavirus
The weekly positivity rate in the country currently stands at 0.35 per cent and the daily positivity rate is also reported to be 0.29 per cent. |Photo by Viktor Forgacs on Unsplash
IANS New Delhi
2 min read Last Updated : Mar 24 2022 | 10:42 AM IST

India reported 1,938 fresh coronavirus (Covid-19) cases, marginally higher than the previous day's count of 1,778, in a span of 24 hours.

In the same period 67 deaths were also recorded taking the total number of deaths to 516,672, said the Union Health ministry on Thursday morning.

Meanwhile, following a continuous downward trend, India's active caseload has further declined to 22,427 Thursday, constituting 0.05 per cent of the country's total positive cases.

A total of 2,531 patients have recovered in the last 24 hours and the cumulative tally of the recovered patients since the beginning of the pandemic is now at 42,475,588. Consequently, India's recovery rate stands at 98.75 per cent.

Also in the same period, a total of 6,61,954 tests were conducted across the country. India has so far conducted over 78.49 crore cumulative tests.

The weekly positivity rate in the country currently stands at 0.35 per cent and the daily positivity rate is also reported to be 0.29 per cent.

On the vaccination front, India's Covid-19 vaccination coverage has exceeded 182.23 crore as per the provisional reports till 7 a.m. on Thursday morning. This has been achieved through 21,572,370 sessions.

Over 7.2 million adolescents have been administered with the first dose of Covid-19 vaccine since the beginning of the vaccination drive for the 12 to 14 age group, said the ministry.

More than 166.9 million balance and unutilised Covid-19 vaccine doses are still available with the states and union territories to be administered, according to the health ministry as of Thursday morning.

--IANS

avr/dpb

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineHealth Ministry

First Published: Mar 24 2022 | 10:33 AM IST

Next Story